Stryker (NYSE: SYK) announced the completion of the first surgical procedure using its SportSuite Vision application on Apple Vision Pro, performed at Duke Health. The procedure was a hip arthroscopy, according to a company press release.

The FDA granted De Novo authorization for SportSuite Vision on July 17, making it what the agency designated as the first application authorized for intraoperative use with Apple Vision Pro. De Novo authorization is a regulatory pathway for novel, low-to-moderate risk medical devices.

SportSuite Vision displays arthroscopic video alongside HipCheck, HipMap, and CT imaging within the Apple Vision Pro headset, consolidating multiple data sources into a single field of view for the surgeon. The application is indicated specifically for femoroacetabular impingement and labral repair hip arthroscopy procedures.

Chad Mather III, M.D., M.B.A., an orthopedic surgeon at Duke Health who performed the procedure, said, "Using spatial computing enabled me to customize the placement of key clinical information to fit my workflow and access it within the sterile field." Mather is identified as a Stryker consultant.

Matt Moreau, vice president and general manager of Stryker's Sports Medicine business, said the technology is intended to move the company "closer to a truly connected digital operating room."

Per the product's indication, virtual images from the headset are to be used by the surgeon alongside traditional monitors used by other operating room staff, rather than as a standalone replacement for existing display systems.

Stryker is headquartered in Portage, Mich.